Summit Therapeutics Inc.

NASDAQ: SMMT · Real-Time Price · USD
26.67
0.22 (0.83%)
At close: Aug 15, 2025, 3:59 PM
26.50
-0.64%
After-hours: Aug 15, 2025, 07:37 PM EDT

Summit Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-57.95 -2.63 -10.43 -2.8
PEG Ratio
0.84 -0.02 0.18 -0.11
PS Ratio
n/a n/a 1.17K 137.16
PB Ratio
32.99 20.82 6.49 2.98
P/FCF Ratio
-90.17 -21.03 -19.47 -3.4
P/OCF Ratio
-90.26 -21.07 -19.76 -3.42
OCF/S Ratio
n/a n/a -59.04 -40.13
Debt / Equity Ratio
0.02 1.37 4.10 0.03
Quick Ratio
10.15 9.30 9.16 3.52
Current Ratio
10.15 9.30 16.93 3.80
Asset Turnover
n/a n/a 0.00 0.02
Interest Coverage
0.04 -5.45 -13.55 -306.71
Return on Equity
-0.57 -7.91 -0.62 -1.06
Return on Assets
-0.51 -3.03 -0.12 -0.78
Return on Invested Capital
n/a -0.48 -0.09 -0.97
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a -2.57 1.00
Net Profit Margin
n/a n/a -111.86 -48.98
Pretax Profit Margin
n/a n/a -111.86 -48.98
Operating Profit Margin
n/a n/a -84.67 -47.64
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a -103.82 -47.49